Effect of endothelin on bladder contraction: potential role in bladder hyperactivity.

Area of Science:

• Cardiovascular Physiology
• Urology
• Endocrinology

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor peptide.
• ET-1 plays a role in regulating blood pressure and urinary function.
• Endothelin receptor subtypes ET(A) and ET(B) mediate ET-1's effects.

Purpose of the Study:

• To investigate the effects of endothelin-1 on micturition volume and arterial pressure in rats.
• To determine the role of ET(A) and ET(B) receptors in mediating these effects.
• To compare ET-1 responses in spontaneously hypertensive rats versus normotensive rats.

Main Methods:

• Intravenous infusion of endothelin-1 and sarafotoxin 6c in rats.
• Administration of ET(A)/ET(B)-non-selective (SB 217242) and ET(A)-selective (SB 247083) endothelin antagonists.
• Measurement of mean arterial pressure and micturition volume.
• Radioligand binding studies to assess ET(A)/ET(B) receptor expression.

Main Results:

• Endothelin-1 infusion decreased mean micturition volume and increased mean arterial pressure.
• These effects were antagonized by SB 217242 and SB 247083, indicating involvement of ET(A) receptors.
• ET(B)-selective agonist sarafotoxin 6c mimicked ET-1's effects on blood pressure and micturition.
• Spontaneously hypertensive rats exhibited a lower baseline micturition volume and a greater response to ET-1 compared to normotensive rats.
• No significant differences in ET(A)/ET(B) receptor expression were found between rat strains.

Conclusions:

• Endothelin-1, acting via ET(A) and potentially ET(B) receptors, reduces micturition volume and elevates arterial pressure.
• Hypertension may be associated with an enhanced sensitivity to endothelin-1's effects on the urinary system and vasculature.
• Further research is warranted to elucidate the specific roles of ET receptor subtypes in voiding dysfunction and hypertension.